Developmental delay (DD) is defined as any significant lag in a child's physical, cognitive, emotional, or social maturity when compared to established norms. Intellectual disability (ID) is classified by neurocognitive impairments as well as significant limitations in adaptive living skills. Autism spectrum disorders (ASDs) represent a neurodevelopmental continuum with varying degrees of social impairment. Laboratory testing should be considered as part of a comprehensive evaluation for individuals with ASD and/or DD/ID (with or without comorbidities) to assist with decisions about treatment and management. An initial workup should include chromosomal microarray (CMA), which offers the highest estimated diagnostic yield in individuals with unexplained DD/ID, ASD, and multiple congenital anomalies (MCAs). CMA is preferred to karyotyping as a first-tier test. Screening for fragile X syndrome and, in some situations, metabolic testing, is also recommended.
Refer to ARUP Laboratories’ test offerings below.
ARUP Laboratory Tests
Giemsa Band/Genomic Microarray (Oligo-SNP Array)
Polymerase Chain Reaction/Capillary Electrophoresis
Tandem Mass Spectrometry/Electrophoresis/Spectrophotometry/ Gas Chromatography-Mass Spectrometry/Liquid Chromatography-Tandem Mass Spectrometry/Quantitative Liquid Chromatography-Tandem Mass Spectrometry, Genomic Microarray (Oligo-SNP Array), Polymerase Chain Reaction/Capillary Electrophoresis